Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Kedbumin Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's offering.
This Kedbumin market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.
Growth during the historic period can be attributed to the increasing prevalence of liver and renal diseases, a rising incidence of burns and trauma, growing awareness of the benefits of albumin therapies, enhanced regulatory approvals for albumin-based products, and the increasing use of albumin in surgeries and post-operative care.
Growth during the forecast period is expected to be driven by a rising aging population with associated chronic diseases, increasing global healthcare expenditure, growing demand for effective critical care solutions, a heightened focus on patient-centric treatment options, and government support for plasma collection and albumin therapies. Key trends anticipated include a shift toward personalized medicine and individualized treatments, growth in parenteral nutrition solutions utilizing albumin, increased adoption of albumin-based treatments in low-income regions, expansion of non-hospital settings offering albumin therapies, and the adoption of combination therapies involving albumin.
The increasing prevalence of chronic diseases is expected to drive the growth of the kedbumin market in the future. Chronic diseases are conditions that persist for three months or longer and can worsen over time. Kedbumin helps manage complications such as ascites and spontaneous bacterial peritonitis by improving circulatory function and reducing fluid buildup. For example, in January 2023, The National Center for Biotechnology Information, part of the US-based National Library of Medicine, reported that the number of Americans aged 50 and older with at least one chronic condition is projected to rise by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Thus, the growing prevalence of chronic diseases is a key factor driving the growth of the kedbumin market.
The expanding aging population is expected to further fuel the growth of the kedbumin market. This demographic, consisting of individuals aged 65 and older, is growing due to increased life expectancy and lower birth rates. Advances in healthcare, medical technology, and improved living conditions have contributed to this trend.
Kedbumin, a plasma-derived albumin solution, assists the aging population by managing conditions such as hypovolemia, hypoalbuminemia, and associated complications, leading to improved health and recovery outcomes. For instance, in January 2024, statistics from the Population Reference Bureau (PRB), a US-based nonprofit organization, projected that the number of Americans aged 65 and older will grow from 58 million in 2022 to 82 million in 2050, a 47% increase. Their proportion of the total population will rise from 17% to 23%. As a result, the growing aging population is a driving force for the kedbumin market.
Key Topics Covered:
1. Executive Summary
2. Kedbumin Market Characteristics
3. Kedbumin Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route of Administration (ROA)
3.3. Mechanism of Action (MOA)
3.4. Safety and Efficacy
4. Kedbumin Market Trends and Strategies
5. Kedbumin Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market
6. Global Kedbumin Growth Analysis and Strategic Analysis Framework
6.1. Global Kedbumin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis of End Use Industries
6.3. Global Kedbumin Market Growth Rate Analysis
6.4. Global Kedbumin Historic Market Size and Growth, 2019-2024, Value ($ Million)
6.5. Global Kedbumin Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Million)
6.6. Global Kedbumin Total Addressable Market (TAM)
7. Global Kedbumin Pricing Analysis & Forecasts
8. Kedbumin Market Segmentation
8.1. Global Kedbumin Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- Treatment of Hypoalbuminemia
- Fluid Resuscitation
- Management of Liver Diseases
- Treatment of Burns and Trauma
- Other Therapeutic Applications
8.2. Global Kedbumin Market, Segmentation by Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- Injectable Formulation
- Lyophilized Powder For Reconstitution
8.3. Global Kedbumin Market, Segmentation by Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- Pediatric Patients
- Adult Patients
- Geriatric Patients
8.4. Global Kedbumin Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- Direct Sales
- Wholesalers and Distributors
- Retail Pharmacies
- Online Pharmacies
8.5. Global Kedbumin Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
- Hospitals
- Specialty Clinics
- Home Healthcare Providers
- Pharmaceutical and Biotechnology Companies
- Research Institutions
9. Global Kedbumin Epidemiology of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence and Prevalence of Clinical Indications
10. Kedbumin Market Regional and Country Analysis
10.1. Global Kedbumin Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Kedbumin Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
For more information about this report visit https://www.researchandmarkets.com/r/o10wr9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
